Orphan designation: 2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid Treatment of systemic sclerosis, 12/03/2013 Withdrawn

Orphan designation: 2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid Treatment of systemic sclerosis, 12/03/2013 Withdrawn

Orphan designation: autologous adipose tissue-derived mesenchymal stem cells Treatment of thromboangiitis obliterans (Buerger's disease), 20/03/2017 Withdrawn

Orphan designation: autologous adipose tissue-derived mesenchymal stem cells Treatment of thromboangiitis obliterans (Buerger's disease), 20/03/2017 Withdrawn

Orphan designation: nimorazole Treatment of squamous-cell carcinoma of the head and neck in patients undergoing radiotherapy, 23/02/2011 Withdrawn

Orphan designation: nimorazole Treatment of squamous-cell carcinoma of the head and neck in patients undergoing radiotherapy, 23/02/2011 Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.